FOXD1 knock down in the non-β1,4-N-acetylgalactosaminyltransferase 2 (B4GALNT2) expresser cell line SW948 stimulated B4GALNT2. Thus, FOXD1 and miR-204-5p emerged as crucial new player of B4GALNT2 down-regulation in colorectal cancer.
[Scientific Reports]